Abbreviations {#nomen0010}
=============

AREs

:   Antioxidant response elements

CnC

:   Cap 'n' collar

DDR

:   DNA damage response

DSBs

:   Double-strand DNA breaks

EpREs

:   Electrophile responsive elements

ERK

:   Extracellular signal--regulated kinase

γ-GCS

:   γ-Glutamyl-cysteine synthetase

18α-GA

:   18α--Glycyrrhetinic acid

GSTs

:   Glutathione S transferases

H2DCFDA

:   2′, 7′-Dichlorodihydrofluorescein diacetate

HGPS

:   Hutchinson--Gilford progeria syndrome

HO-1

:   Heme oxygenase 1

HR

:   Homologous recombination

Keap-1

:   Kelch-like ECH associated protein 1

Maf

:   Musculoaponeurotic fibrosarcoma oncogene

MAPKs

:   Mitogen-activated protein kinases

MMC

:   Mitomycin

NER

:   Nucleotide excision repair

NQO-1

:   NAD(P)H quinone oxidoreductase-1

Nrf2

:   Nuclear factor (erythroid-derived-2)-like 2

PI3K/AKT

:   Phosphatidylinositol-3-kinase

PKC

:   Protein kinase C

ROS

:   Reactive oxygen species

TXNRD1

:   Thioredoxin reductase 1

UPR

:   Unfolded protein response

1. Introduction {#sec1}
===============

Cells are constantly under various kinds of stress with oxidative, proteotoxic and DNA damage challenges being the most important and frequent ones. Consequently, cells are continuously alert to ensure genome and proteome integrity in the face of challenges posed by exogenous (such as UV irradiation, ionizing radiation or chemicals, among others) and endogenous (such as reactive oxygen species -ROS-, among others) sources of damage. To cope with the various types of stress, cells have developed complex surveillance and repair mechanisms, including the DNA damage response (DDR; \[[@bib1]\]), the unfolded protein response (UPR; \[[@bib2]\]) or the activation of master transcription factors that regulate the cellular response to other stresses with oxidative stress arguably being the most important \[[@bib3]\].

Nuclear factor (erythroid-derived-2)-like 2 (Nrf2) is a master transcription factor, which is induced to orchestrate the cellular antioxidant response upon oxidative/electrophilic stress \[[@bib4]\]. Nrf2 belongs to the CnC (Cap 'n' collar) family of leucine zipper transcription factors with many well-characterized target genes with antioxidant and detoxifying properties, such as thioredoxins, γ-Glutamyl-cysteine synthetase (γ-GCS), glutathione S transferases (GSTs), NAD(P)H quinone oxidoreductase-1 (NQO-1), heme oxygenase 1 (HO-1) and several proteasome subunits, among others \[[@bib5]\]. In the absence of oxidative or electrophilic stress, detectable cytoplasmic Nrf2 levels are low, mainly due to its proteasome-dependent degradation promoted by Kelch-like ECH associated protein 1 (Keap-1; \[[@bib6]\]) which is its negative regulator. In contrast, under conditions of cellular stress, key cysteine residues of Keap1 are modified leading to conformational changes that prevent Nrf2 ubiquitination \[[@bib7]\] with subsequent stabilization and nuclear translocation of Nrf2. Once in the nucleus, Nrf2 forms heterodimers with small Maf (musculoaponeurotic fibrosarcoma oncogene) proteins and thus recognizing and binding to antioxidant response elements (AREs; \[[@bib8]\]) also known as electrophile responsive elements (EpREs; \[[@bib9]\]) that are present in the promoter regions of its target genes. As a consequence, the necessary transcriptional complexes are recruited and transcription of the appropriate target genes is upregulated. Several signal transduction pathways have been shown to activate Nrf2 through phosphorylation, including the mitogen-activated protein kinases (MAPKs), phosphatidylinositol-3-kinase (PI3K/AKT), and protein kinase C (PKC) \[[@bib10]\].

Mitomycin C (MMC) is a bi-alkylating and DNA crosslinking agent \[[@bib11]\] that causes high levels of cytotoxicity through the induction of various types of DNA damage. In addition to its direct effect on DNA topology, MMC\'s action has also been linked to the generation of ROS and thereby the induction of oxidative stress-mediated DNA damage \[[@bib12],[@bib13]\]. Thus, a vicious circle ensues, whereby enhanced ROS production leads to a variety of DNA lesions that cause additional DNA damage. DNA repair pathways such as nucleotide excision repair (NER) or homologous recombination (HR) have been shown to be induced following MMC-mediated DNA damage \[[@bib13]\].

The term phytochemicals refers to naturally occurring compounds that were shown to possess beneficial properties for human health. In the last decades, research on phytochemicals has flourished, continuously yielding evidence that consumption of foods rich in phytochemicals can provide health gains. Nevertheless, there are still insufficient data to formulate specific recommendations regarding phytochemical intake. 18α-glycyrrhetinic acid (18α-GA) is a bioactive component mainly derived from *Glycyrrhiza radix* \[[@bib14]\]. It is a pentacyclic triterpene glycoside with various attributed pharmacological activities such as anti-oxidative \[[@bib15],[@bib16]\], anti-inflammatory \[[@bib17]\], anti-proliferative (in cancer cells; \[[@bib18]\]) but also pro-proliferative (in primary cells; \[[@bib19]\]) activities. More recently, we have also shown that it exerts pro-longevity action in human primary fibroblasts \[[@bib15]\] as well as in *C. elegans* \[[@bib16]\] through Nrf2/SKN-1-mediated proteasome activation.

In this study, we investigated the potential protective properties of 18α-GA against DNA damage induced by MMC treatment. We identified an Nrf2-mediated protective effect against MMC-induced cell death and we demonstrated that it is ERK-dependent. In total, our results reveal an additional beneficial effect of the Nrf2 activator 18α-GA which further supports its status as a highly promising phytochemical compound.

2. Materials and methods {#sec2}
========================

2.1. 18α-GA treatment {#sec2.1}
---------------------

18α-GA (Sigma-Aldrich, Munich, Germany, ≥98% purity) was dissolved as stock solution of 4 mg/ml in DMSO and stored at −20 °C. Cells were exposed to 2 μg/ml 18α-GA or the same amount of DMSO (control) for 24 h before treatment with 20 μg/ml MMC for 1 h. Whenever 24 h recovery was performed, this was done in the presence of 2 μg/ml 18α-GA or DMSO. Since it has been shown that even low DMSO concentrations (\>1%) may show antioxidant effects and may influence the experimental results, the final concentration of DMSO in our experiments was 0.05%; no difference was detected between untreated and DMSO-treated cells in agreement with previous work \[[@bib20],[@bib21]\].

2.2. MMC treatment {#sec2.2}
------------------

Mitomycin C (Applichem Panreac, Glenview, IL, USA) was dissolved as stock solution of 0.5 mg/ml in water and stored at 4 °C in the dark. Cells were exposed to 20 μg/ml MMC or water (control) following 24 h pre-treatment with 2 μg/ml 18α-GA or DMSO.

2.3. Antibodies {#sec2.3}
---------------

Antibodies against phospho-ERK (p-ERK; sc-7383), phosho-c-JUN (p-c-JUN; sc-822), GAPDH (sc-25778) and horseradish peroxidase-conjugated secondary antibodies were purchased from Santa Cruz (Heidelberg, Germany). Antibody against phospho-Histone H2AX (Ser139) (\#2577) was purchased from Cell signaling (Danvers, MA, USA). The Alexa Fluor 488 secondary antibody used for confocal analysis was purchased from Invitrogen (Carlsbad, CA, USA, Α21206).

2.4. Cell culture {#sec2.4}
-----------------

HFL-1 human embryonic fibroblasts were obtained from the European Collection of Cell Cultures and were cultured in Dulbecco\'s modified Eagle\'s medium (Invitrogen, Carlsbad, CA, USA) supplemented with 10% fetal bovine serum (Invitrogen, Carlsbad, CA, USA), 2 mM glutamine and 1% non-essential amino acids. HFL-1 cells were maintained at 37 °C, 5% CO2 and 95% humidity and they were subcultured when they reached confluency at a split ratio of 1:2. Cell number for each assay was determined in duplicates using a Coulter Z2 counter (Beckman, Brea, CA, USA).

E8.T4 cells, an L929 cells subclone, were cultured in the above mentioned medium supplemented with 200 μg/ml geneticin (G418 sulfate; Invitrogen, Carlsbad, CA, USA). This subclone expresses a mutated, non-functional form of Nrf2 whereas expression of the wild type and functional Nrf2 form is induced following treatment with 1 μg/ml of doxocycline (Sigma-Aldrich, Munich, Germany), a tetracycline analogue.

2.5. RNA isolation and real-time PCR analysis {#sec2.5}
---------------------------------------------

RNA was extracted using Trizol (Invitrogen, Carlsbad, CA, USA) and converted into cDNA with the iScript cDNA synthesis kit (Bio-Rad Laboratories, Hercules, USA). Real-time PCR reactions were performed in triplicate in a CFX Connect Real-time PCR system (Bio-Rad Laboratories, Hercules, USA). Primers used are summarized in [Table 1](#tbl1){ref-type="table"}. Data were analyzed using the comparative 2^-ΔΔCt^ method and are presented as the fold difference in mRNA transcript abundance in 18α-GA-treated cells relative to control (DMSO-treated) cells, normalized to the *GAPDH* gene, unless otherwise indicated.Table 1Primers used for Real Time PCR analysis.Table 1GeneForward primer (5'→3′)Reverse primer (5'→3′)*NRF2*AAACCAGTGGATCTGCCAACGACCGGGAATATCAGGAACA*NQO1*AGTCCCTGCCATTCTGAAAGAAAGCACTGCCTTCTTACTCC*TXNRD1*GGAACGCTCTCGGAATTGGTCTGCCCTCCTGATAAGCC*HO-1*GATAGAAGAGGCCAAGACTGGAATCTTGCACTTTGTTGCT*GAPDH*GAAGGTGAAGGTCGGAGTCATGGGTGGAATCATATTGGAA

2.6. Immunoblot analysis {#sec2.6}
------------------------

Cells were harvested at the indicated time points and lysed in reducing Laemmli buffer. Proteins were then fractionated by SDS-page and transferred to nitrocellulose membranes for probing with appropriate antibodies as previously described \[[@bib22]\]. Secondary antibodies used were conjugated with horseradish peroxidase, and blots were developed with chemiluminescence by using the Clarity™ Western ECL substrate (Bio-Rad Laboratories, Hercules, USA). Protein concentration was determined using the Bradford method with bovine serum albumin as standard. Each blot was repeated at least three times. Probing with GAPDH antibody was used to verify equal loading.

2.7. Confocal analysis {#sec2.7}
----------------------

HFL-1 cells were grown on coverslips and treated with 18α-GA for 24 h followed by treatment with MMC for 1 h and a 24 h recovery period in the presence of 18α-GA or DMSO, then fixed in 4% parafolmaldehyde followed by cell permeabilization with 0.2% Triton X-100 in phosphate-buffered saline (PBS). Cells were incubated with the appropriate antibody overnight, followed by incubation with Alexa Fluor 488 secondary antibody (Invitrogen, Carlsbad, CA, USA). Nuclei were stained with DAPI (Sigma, Munich, Germany). Slides were mounted using Prolong Gold anti-fade reagent (Life technologies, Carlsbad, CA, USA) and analyzed using a Leica TCS SPE confocal laser scanning microscope (Leica Lasertechnik GmbH, Heidelberg, Germany) equipped with ACS APO 63X/1.30 NA OILCS objective. Fluorescence was excited with a 488 nm line and collected with a 517 nm filter. The LAS AF software (Leica Lasertechnik GmbH, Heidelberg, Germany) was used for image acquisition.

2.8. Survival and cell death detection {#sec2.8}
--------------------------------------

Cell death was assessed through scoring of detached cells in the culture supernatant after pre-incubation of the cultures with 18α-GA or DMSO for 24 h, 1 h incubation with MMC and a 24 h recovery period in the presence of 18α-GA or DMSO in triplicate using a Coulter Z2 counter (Beckman, Brea, CA, USA). For MMC optimization, cell viability of HFL-1 cell cultures was assessed through scoring of attached MMC-treated cells after 1 h of incubation with various MMC concentrations in triplicate using a Coulter Z2 counter (Beckman, Brea, CA, USA). E8.T4 cells \[[@bib23]\] were continuously supplemented with 1 μg/ml doxocycline (to induce the functional form of Nrf2) or were not supplemented with doxocycline (expression of mutated Nrf2 form) and cell death was assessed in both cultures as described above.

For determination of the survival ratio through crystal violet staining, cells treated as described above were fixed in 4% paraformaldehyde for 20 min and then stained with 0.2% crystal violet in distilled water. Cells were washed with water, air dried and the dye was eluted with 30% acetic acid. Viability was assessed by measuring dye absorbance at 595 nm using the Safire2 Multi-detection Microplate Reader (Tecan, Grödig, Austria).

2.9. Comet assay {#sec2.9}
----------------

Cells were pre-treated with 18α-GA or DMSO followed by treatment with MMC for 1 h and were then left for a 24 h recovery period in the presence of 18α-GA or DMSO. Cells were then harvested and used in comet assay analysis of DNA damage. After the detachment of the cells with trypsin-EDTA, they were washed with PBS, suspended in 1% low melting point agarose (LMP agarose) and maintained at 37 °C. Approximately 10000 cells/sample in 70 μl of PBS were placed on an agarose pre-coated microscope slide and placed at 4 °C for 30 min. The slides were then immersed in cold lysis buffer (2.5 M NaCl, 0.1 M EDTA, 10 mM Tris, 1% Triton-X 100, pH 10) to lyse the cells and to unfold the DNA. The samples were kept for 2 h at 4 °C in the dark and were then placed in a horizontal electrophoresis unit containing electrophoresis buffer (0.3 M NaOH and 1 mM EDTA). Before electrophoresis, cells were maintained in the same buffer for 40 min to allow DNA unwinding and to expose the sites of damage. Electrophoresis was performed for 30 min at 4 °C at 25 V and approximately 255 mA. The samples were then placed in neutralization buffer (0.4 M Tris, pH 7.4) for 10 min, washed with distilled water and air dried. SYBR GOLD was added to each sample for 30 min in the dark and cell were observed using a fluorescence microscope (Zeiss, Oberkochen, Germany).

2.10. Measurement of reactive oxygen species (ROS) {#sec2.10}
--------------------------------------------------

Detection of ROS was performed with 2′, 7′-dichlorodihydrofluorescein diacetate H2DCFDA (Molecular Probes, Invitrogen, Carlsbad, CA, USA) as previously described \[[@bib24]\]. HFL-1 cells pre-treated with 18α-GA or DMSO for 24 h and then treated with MMC for 1 h, were resuspended in PBS with or without H2DCFDA at a final concentration of 10 μM (loading buffer) and incubated at 37 °C for 30 min. The loading buffer was then removed; cells were resuspended in pre-warmed complete medium and incubated at 37 °C for 5 min. The absorption and the emission of the oxidation product were measured at 493 and 520 nm, respectively using the Safire2 Multi-detection Microplate Reader (Tecan, Grϕdig, Austria). Each sample was measured in triplicate.

2.11. Statistical analysis {#sec2.11}
--------------------------

Statistical analysis and graphs were produced using Prism (GraphPad Software Inc, La Jolla, CA, USA). Data in all assays (including blots quantification) are depicted as the average of at least 2 independent experiments. Error bars denote ± SEM. Student\'s t-test and ANOVA were used for comparisons. Asterisks denote p-values as follows: \*p \< 0.05, \*\*p \< 0.01, \*\*\*p \< 0.001, NS (not significant). Quantification of the adjusted ratio of each protein to GAPDH (using Image Studio Lite Ver 5.2, Li-Cor, Lincoln, NE, USA) expressed as (%) percentage of the DMSO-treated control cells (arbitrarily set to 100%) appears in graphs next to each representative blot.

3. Results {#sec3}
==========

3.1. 18α-GA protects against MMC-induced cell death {#sec3.1}
---------------------------------------------------

We initially exposed HFL-1 cells to various concentrations of the genotoxic agent MMC (10, 15 and 20 μg/ml MMC). There was a statistically significant difference between treatment groups as determined by one-way ANOVA (*F*(3,8) = 290.5, p \< 0.001). A Tukey post-hoc test revealed that cell survival percentage was significantly lower upon treatment with (a) 10 μg/ml MMC (59.1 ± 0.8, p \< 0.001), (b) 15 μg/ml MMC (44.5 ± 0.5, p \< 0.001) and (c) 20 μg/ml MMC (38.5 ± 0.5, p \< 0.001) as compared to DMSO-treated control group (100 ± 5.5). Cell survival percentage was significantly lower upon treatment with 15 μg/ml MMC (44.5 ± 0.5, p \< 0.001) and 20 μg/ml MMC (38.5 ± 0.5, p \< 0.001) as compared to treatment with 10 μg/ml MMC (59.1 ± 0.8). There was no significant difference between treatment with 15 μg/ml MMC and 20 μg/ml MMC (p = 0.118). Since 20 μg/ml MMC for 1 h led to death more than 60% of the cellular population (less than 40% survival), this concentration was chosen for all subsequent experiments ([Fig. 1](#fig1){ref-type="fig"}A; asterisks display significance levels of each MMC concentration group compared to the DMSO-treated control group). We then pre-treated HFL-1 cells with 2 μg/ml 18α-GA or DMSO for 24 h (a concentration shown to be beneficial in previous work; \[[@bib15],[@bib16]\]), followed by a 1 h treatment with MMC and a 24 h recovery period in the presence of 18α-GA or DMSO. Survival was assessed by measuring survival ratio through crystal violet staining ([Fig. 1](#fig1){ref-type="fig"}B) and by measuring the number of dead cells in the culture supernatant ([Fig. 1](#fig1){ref-type="fig"}C); in the presence of 18α-GA, cells were better able to survive from MMC treatment.Fig. 118α-GA decreases cell death induced by MMC. (A) Optimization of MMC concentration leading to death more than 60% of the cell population as assessed by cell survival (expressed as percentage (%) of live cells). Number of live cells in DMSO-treated cells were set to 100%. Percentage (%) of (B) survival ratio following crystal violet staining, and (C) cell death in HFL-1 cells treated with 18α-GA or DMSO for 24 h and then subjected to genotoxic stress with MMC for 1 h followed by a 24 h recovery in 18α-GA or DMSO. Number of (B) dye absorbance and (C) dead cells in DMSO-treated cells were set to 100%. All values are reported as mean of three independent experiments. Error bars denote ±SEM.\*p \< 0.05, \*\*\*p \< 0.001, asterisks in (A) display significance levels of each MMC concentration group compared to the DMSO-treated control group. (For interpretation of the references to colour in this figure legend, the reader is referred to the Web version of this article.)Fig. 1

We then investigated whether the increased survival is due to lower DNA damage rates. Phosphorylation of histone H2A variant H2AX at Ser 139 (γH2AX) is abundant, fast, and correlates well with double-strand DNA breaks (DSBs) that are rapidly generated when cells are exposed to DNA-damaging agents such as MMC. Thus, it is a very sensitive marker that can be used to examine the DNA damage produced and the subsequent repair of the DNA lesions \[[@bib25]\]. DNA damage foci were increased massively 24 h after MMC treatment in cells treated with MMC as compared to cells pre-treated with 18α-GA and then treated with MMC ([Fig. 2](#fig2){ref-type="fig"}A), thus verifying the protective effect of 18α-GA against MMC-mediated DNA damage. To further visualize the protection against DNA damage, comet assay was performed. As shown in [fig. 2](#fig2){ref-type="fig"}B, 18α-GA pre-treatment prevented comet formation, thus verifying the protective role of 18α-GA against DNA damage.Fig. 2Reduced DNA damage by MMC in the presence of 18α-GA. Representative images of (A) DNA damage foci containing γH2AX and the quantification of cells containing foci in each condition (at least 80 cells measured/condition, number of foci in DMSO-treated cells set as 100%), and (B) comet fluorescence microscopy visualization in HFL-1 cells pre-treated with 18α-GA or DMSO for 24 h and then subjected to genotoxic stress with MMC for 1 h followed by a 24 h recovery in 18α-GA or DMSO. Error bars denote ±SEM.\*p \< 0.05, \*\*\*p \< 0.001.Fig. 2

3.2. The protective effect of 18α-GA against MMC-induced cell death is mediated by Nrf2 {#sec3.2}
---------------------------------------------------------------------------------------

In our previous studies, we have shown that 18α-GA is an Nrf2 activator \[[@bib15],[@bib16]\]. We therefore sought to investigate whether the observed 18α-GA protection is Nrf2-dependent. We used E8.T4 cells that express the functional form of Nrf2 upon doxocycline supplementation \[[@bib23]\]. Cells expressing the functional Nrf2 (in the presence of doxocycline) and cells expressing the mutated Nrf2 (in the absence of doxocycline) were pre-treated with 18α-GA or DMSO for 24 h, followed by 1 h treatment with MMC and a 24 h recovery period in the presence of 18α-GA or DMSO and cell death was assessed. Pre-treatment of cells expressing the functional Nrf2 with 18α-GA led to only \~20% cell death following MMC treatment as compared to the cell death levels in their relative DMSO/MMC control culture (set as 100%; [Fig. 3](#fig3){ref-type="fig"}A). The relative levels of cell death in cells expressing the mutated Nrf2 were \~80% as compared to their relative DMSO/MMC control culture (set as 100%; [Fig. 3](#fig3){ref-type="fig"}A), thus being significantly higher than the ones in the cultures expressing the functional Nrf2. The observation that 18α-GA treatment also decreased cell death in the cells expressing the mutated Nrf2 by \~20% as compared to the relative DMSO/MMC control culture could suggest an additional Nrf2-independent role of 18α-GA or a potential leakiness of the on/off gene expression system that should be further investigated.Fig. 3Activation of Nrf2 and its target genes by 18α-GA during DNA damage. (A) Percentage (%) of cell death in E8.T4 cells supplemented (expression of functional Nrf2) or non-supplemented (expression of mutated Nrf2) with 1 μg/ml doxocycline, treated with 18α-GA or DMSO for 24 h and then subjected to genotoxic stress with MMC for 1 h followed by a 24 h recovery in 18α-GA or DMSO. Number of dead cells in DMSO/MMC-treated cells were set to 100%. (B) Real-time PCR analysis of *NRF2*, *NQO1*, *TXNRD1* and *HO-*1 mRNA levels (expression levels of each gene were arbitrarily set to 1 in DMSO-treated cells, *GAPDH* mRNA levels were used as normalizer) in cells pre-treated with 18α-GA or DMSO for 24 h and then treated or not with MMC for 1 h. Error bars denote ±SEM.\*\*p \< 0.01, \*\*\*p \< 0.001, NS not significant.Fig. 3

We then sought to further investigate the potential Nrf2 activation in our experimental set up. The mRNA expression levels of *NRF2* and its transcriptional target genes, namely *NQO1* and *TXNRD1* (thioredoxin reductase 1), were found to be significantly induced in the presence of 18α-GA ([Fig. 3](#fig3){ref-type="fig"}B). Moreover, the mRNA levels of these genes were significantly higher in 18α-GA/MMC-treated cells as compared to DMSO/MMC-treated cells ([Fig. 3](#fig3){ref-type="fig"}B). Not all Nrf2 target genes were induced; *HO-1* was not induced under our experimental conditions ([Fig. 3](#fig3){ref-type="fig"}B).

While the canonical mechanism of action of MMC involves alterations in DNA topography that induce DNA damage, MMC has also been shown to effect ROS production; formation of monoadducts and free radical-induced DNA strand breaks have been shown to underlie its toxic effect \[[@bib12],[@bib13]\]. Since we have previously shown that 18α-GA possesses anti-oxidant properties \[[@bib15],[@bib16]\], we assessed ROS levels in our experimental setting. Indeed, cells treated with 18α-GA exhibited significantly lower ROS levels as compared to their DMSO-treated counterparts ([Fig. 4](#fig4){ref-type="fig"}A). Moreover, cells pre-treated with 18α-GA before the addition of MMC, exhibited even lower ROS levels as compared to their DMSO/MMC-treated counterparts ([Fig. 4](#fig4){ref-type="fig"}B); it seems like the addition of the stressor (MMC) is an extra boost for the Nrf2 pathway in accordance with a previous study \[[@bib26]\]. These results are consistent with the induction of *NQO1* and *TXNRD1* genes ([Fig. 3](#fig3){ref-type="fig"}B), which are both known to be involved in cellular antioxidant responses \[[@bib27],[@bib28]\].Fig. 4Cytoprotective effect of 18α-GA against oxidative stress. Percentage (%) of ROS levels in (A) HFL-1 cells treated with 18α-GA or DMSO for 24 h, and in (B) HFL-1 cells treated with 18α-GA or DMSO for 24 h and then treated with MMC for 1 h. Levels of ROS in DMSO-treated cells were arbitrarily set to 1. Error bars denote ±SEM.\*p \< 0.05, \*\*p \< 0.01.Fig. 4

3.3. 18α-GA-mediated Nrf2 induction is ERK-dependent {#sec3.3}
----------------------------------------------------

Earlier studies have shown that the cellular defense capacity is dependent on the activation of the ERK/Nrf2 signaling pathway. Moreover, phosphorylation of ERK is negatively influenced by pro-oxidant exposures \[[@bib29]\], while p-ERK is induced by several antioxidant compounds like red ginseng \[[@bib30]\], morin \[[@bib31]\], curcumin \[[@bib32]\] and sulforaphane \[[@bib33]\], among others. Treatment of cells with 18α-GA led to increased phosphorylation of ERK whereas treatment with MMC negatively influenced ERK phosphorylation ([Fig. 5](#fig5){ref-type="fig"}A). Nevertheless, the MMC-mediated decrease in ERK phosphorylation was attenuated by 18α-GA supplementation ([Fig. 5](#fig5){ref-type="fig"}A). In accordance with p-ERK levels, phosphorylation of c-JUN was reduced upon MMC treatment. Upon pre-treatment with 18α-GA and MMC challenge, p-c-JUN levels were significantly elevated as compared to the levels found in DMSO/MMC-treated cells ([Fig. 5](#fig5){ref-type="fig"}A). The increased levels of p-c-JUN are consistent with the enhanced expression of *NQO1* upon 18α-GA supplementation, since it has been shown that Nrf2 cooperates with p-c-JUN to drive *NQO1* transcription \[[@bib34]\].Fig. 518α-GA exerts its protective role against DNA damage through induction of ERK/Nrf2 signaling pathway. (Α) Immunoblot analysis and quantification of p-ERK (number of blots = 5) and p-c-JUN (number of blots = 3) in HFL-1 cells pre-treated with 18α-GA or DMSO for 24 h and then subjected to genotoxic stress with MMC for 1 h. Representative gels are shown. (B) DNA damage foci containing γH2AX and the quantification of cells containing foci in each condition (at least 80 cells measured/condition, number of foci in DMSO-treated cells set as 100%), and (C) real time PCR analysis of *NQO1* and *TXNRD1* mRNA levels (expression levels of each gene were arbitrarily set to 1 in DMSO-treated cells or DMSO/PD035901-treated cells, *GAPDH* mRNA expression was used as normalizer) in HFL-1 cells pre-treated with 18α-GA or DMSO for 24 h and then subjected to genotoxic stress with MMC for 1 h in the presence or absence of PD035901 inhibitor followed by a 24 h recovery in 18α-GA or DMSO. Error bars denote ±SEM. \*p \< 0.05, \*\*p \< 0.01, \*\*\*p \< 0.001, NS not significant.Fig. 5

Lastly, we measured DNA damage foci 24 h after MMC treatment in cells pre-treated with 18α-GA or DMSO in the presence or absence of the specific MEK inhibitor, PD035901 that effectively prevents ERK phosphorylation. Although there were significantly fewer DNA damage foci 24 h after MMC treatment in 18α-GA/MMC-treated cells as compared to DMSO/MMC-treated cells (\~2-fold less foci; [Fig. 2](#fig2){ref-type="fig"}A), the beneficial effect of 18α-GA was abolished in the presence of PD035901 ([Fig. 5](#fig5){ref-type="fig"}B), suggesting that this protective action is ERK-dependent. To further link Nrf2 induction to the ERK pathway, we measured the mRNA expression levels of the Nrf2 target genes *NQO1* and *TXRDN1* in cells treated with 18α-GA or DMSO in the presence of PD035901. Indeed, while those genes were upregulated upon treatment with 18α-GA and upon combined treatment with 18α-GA and MMC, the induction was abolished (either totally or near totally) when ERK phosphorylation was inhibited by PD035901 ([Fig. 5](#fig5){ref-type="fig"}C). Taken together, these data indicate that 18α-GA exerts a protective role against MMC genotoxicity through the activation of the ERK/Nrf2 pathway. [Fig. 6](#fig6){ref-type="fig"} summarizes our results and outlines potential mechanisms that drive the protective effects of 18α-GA against MMC.Fig. 6Proposed model for the cytoprotective effect of 18α-GA against MMC cytotoxicity. Apart from the canonical mechanism of action of MMC on DNA topology, MMC alters the cellular redox status, promoting ROS production and contributing to oxidative stress-mediated DNA damage. Moreover, MMC leads to decreased p-ERK levels, thereby limiting Nrf2 activation and its antioxidant effect and further contributing to oxidative stress-mediated DNA damage. 18α-GA induces ERK phosphorylation that promotes Nrf2 phosphorylation and nuclear translocation. Nuclear Nrf2 heterodimerizes with p-c-JUN (among other possible partners) upregulating the transcription of several target genes like *NQO1* and -*TXNRD1* (among others). The proteins encoded by those genes are part of the antioxidant cellular mechanisms leading to reduced ROS levels that normally promote DNA damage. This cascade may be inhibited through treatment with the specific MEK inhibitor PD035901 that effectively prevents ERK phosphorylation thus abolishing the protective effect of 18α-GA against MMC cytotoxicity. 18α-GA may also activate Nrf2 through other pathways as well (e.g. through the redox regulation of Keap1) while it may impact cellular ROS levels through additional direct or indirect mechanisms.Fig. 6

4. Discussion {#sec4}
=============

Constantly growing evidence indicates that dietary compounds exert beneficial effects against various types of damage (mainly oxidative stress-mediated damage), aging and age-related diseases through the modulation of the Nrf2 signaling pathway. Intracellular signaling pathways such as the MAP kinase cascades are crucial in this activation \[[@bib35]\]. In this study, we demonstrate that 18α-GA, which has previously been shown to activate Nrf2, protects cells against MMC-induced cytotoxicity through activation of the ERK/Nrf2 signaling pathway. This is an additional beneficial effect of this dietary compound against DNA damage, which is a stress that all organisms have to cope with continuously.

Nrf2 is one of the pivotal transcription factors regulating the cellular antioxidant response through the directed upregulation of several antioxidant and detoxifying genes \[[@bib5]\]. MMC has been linked to ROS generation \[[@bib12],[@bib13]\] and ROS levels are known to be the main mediators of Nrf2 induction \[[@bib3]\]. It is therefore not surprising that MMC led to Nrf2 activation and to increased expression of antioxidant genes such as *NQO1* and TXNRD1. The observed reduced ROS levels in cells that were pre-treated with 18α-GA even following MMC addition are in accordance with the previously established antioxidant properties of the compound \[[@bib15],[@bib16]\]. Moreover, our results are consistent with data revealing higher sensitivity of Nrf2-deficient human colon cancer cells to MMC exposure; in the absence of Nrf2 and its downstream effects on antioxidant genes, MMC is much more potent as a genotoxic agent \[[@bib36]\]. Consequently, the Nrf2 activation that occurs in our experimental set up is expected to limit MMC\'s genotoxicity.

Our data suggest that Nrf2 activation by 18α-GA is at least partially regulated by the MAPK (ERK1/2) pathway, as MEK-ERK pathway inhibition by the pharmacological inhibitor PD035901 abolished the protective effects of 18α-GA and reduced the expression of Nrf2 target genes following MMC-induced DNA damage. Many phytochemical components with antioxidant properties have been shown to exert their (usually antioxidant) protective effects through the ERK/Nrf2 pathway; red ginseng \[[@bib30]\], morin \[[@bib31]\], curcumin \[[@bib32]\], sulforaphane \[[@bib33]\], genistein \[[@bib26]\] and quercetin \[[@bib37]\] are only few of them. We have previously demonstrated that in *C. elegans* 18α-GA promotes the nuclear translocation of SKN-1 (the ortholog of Nrf2 in *C. elegans*; \[[@bib38]\]) through activation and phosphorylation by PMK-1 (a MAPK family member, ortholog of human MAPK12, 13 and 14) \[[@bib16]\]. Moreover, it has been shown that the ERK-MAPK pathway regulates longevity through SKN-1 and insulin-like signaling in *C. elegans* \[[@bib39]\], and that phytochemicals like resveratrol exert their pro-longevity effects through the MPK-1/ERK/SKN-1 pathway \[[@bib40]\]. Thus, our findings are in agreement with other studies implicating MAPK cascade in Nrf2 activation at both the cellular and organismal level.

Various compounds characterized as Nrf2 activators have been shown to exert protective effects against DNA damage. In most cases, this has been proposed to encompass oxidative stress-mediated DNA damage since most of the challenges (treatment with chemical compounds or irradiation) modulate ROS production in addition to their canonical mechanism of action. For example, ferulic acid, which is a naturally occurring plant flavonoid, protects cells from γ-irradiation-mediated oxidative stress through Nrf2 activation and ROS scavenging \[[@bib41]\]. Similarly, Nrf2-dependent protective action against oxidative stress-induced DNA damage has been shown for morin \[[@bib42]\], fish oil omega-3 fatty acids \[[@bib43]\] and puerarin \[[@bib44]\], among others. Likewise, red raspberry extract was shown to protect against UVB-induced skin photo-damage by activating Nrf2 and its target genes and consequently through the ROS scavenger properties and through protection against inflammatory responses \[[@bib45]\]. Mangiferin has been shown to upregulate NQO1 expression through Nrf2 activation, thereby significantly reducing etoposide-induced DNA damage \[[@bib46]\]. Nevertheless, the redox status of the cells upon etoposide treatment was not investigated to rule out the possibility of oxidative stress-induced DNA damage and consequent Nrf2 activation. Interestingly, despite the vast majority of studies referring to oxidative stress-mediated DNA damage there are also studies reporting a protective effect of Nrf2 against DNA damage independently of ROS. For example, BLAST analysis on upstream regions of DNA repair genes revealed the presence of antioxidant response elements (AREs) and found that many repair genes that are involved in the HR pathway may be regulated by Nrf2 \[[@bib47]\]. Likewise, transcription of 53BP1 during DSBs repair has been shown to be partially dependent on Nrf2 \[[@bib48]\], while BRCA1 has been shown to promote Nrf2 expression through enhanced transcription and reduced degradation \[[@bib49]\]. Additionally, more efficient DNA damage repair was documented in Hutchinson--Gilford progeria syndrome (HGPS) fibroblasts in the presence of the Nrf2 activator sulforaphane \[[@bib50]\]. Our results indicate oxidative stress-mediated DNA damage protection through 18α-GA, without however ruling out the possibility of a ROS-independent action of the compound contributing to the observed Nrf2 activation.

Over the last few years, functional foods have been increasingly attracting attention due to their potential health preserving properties. Such foods are thoroughly investigated to reveal properties that can be exploited to prevent disease, to delay its manifestation and/or to facilitate its treatment. Consumption of natural products with health maintenance claims possesses the advantage that such products may be delivered through a normal diet at any phase of human life, even from a young age. Most importantly, they can exert their positive actions even during preclinical stages of disease initiation when current methods of clinical screening are unable to make a diagnosis. For example, DNA damage occurs daily in cells, yet carcinogenesis requires certain cumulative doses. Therefore, enhancement of cellular resistance or repair capacity against DNA damage through diet that prevents or delays the accumulation of insults is a highly desirable strategy for disease prevention, especially if we refer to natural compounds with limited side effects that we would consume anyway.

5. Conclusions {#sec5}
==============

Our study demonstrates the protective effect of 18α-GA, a pentacyclic triterpenoid already shown to activate the Nrf2/SKN-1 pathway \[[@bib15],[@bib16]\] against DNA damage. Our study suggests that this triterpenoid could be used in a prophylactic (i.e. chemopreventive) or therapeutic strategy against conditions (such as aging) or diseases that are characterized by both oxidative stress and DNA damage.
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